Rajiv de Silva is President at Valeant Pharmaceuticals International, Inc. (VRX). They have made 9 open-market trades across 3 companies since 2009, most recently 2022-11-18.
CIK 0001453140
6 open-market purchases totalling $1.5M since 2009, against 3 sales. Across 6 scored buys the stock is down 12.3% at ninety days, and 12.1 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 83% | 50% |
| Avg Move | -11.3% | -2.9% | -12.3% |
| Alpha | -7.9% | -2.9% | -12.1% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VERO | BUY | 2022-11-18 | 2022-11-22 | $0.20 | $250K | +14.2% | +14.6% | -1.2% |
| ENDP | BUY | 2016-03-07 | 2016-03-07 | $44.50 | $100K | -31.8% | -33.6% | -59.2% |
| ENDP | BUY | 2015-11-11 | 2015-11-12 | $55.52 | $500K | -11.9% | +0.1% | -14.7% |
| VRX | SELL | 2012-11-08 | 2012-11-09 | $54.04 | $4.1M | -12.8% | +0.4% | +0.4% |
| VRX | SELL | 2012-11-06 | 2012-11-08 | $54.38 | $12.0M | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2011-08-12 | 2011-08-16 | $40.40 | $250K | -12.8% | +0.4% | +0.4% |
| VRX | SELL · 10b5-1 | 2010-12-01 | 2010-12-02 | $27.00 | $5.9M | -12.8% | +0.4% | +0.4% |
| VRX | SELL | 2010-06-09 | 2010-06-11 | $45.24 | $1.0M | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-08-24 | 2009-08-25 | $24.98 | $225K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-02-27 | 2009-03-03 | $17.28 | $200K | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.